ABC.L Regulatory News (ABC)

RNS REACH

ABCAM PLC

("Abcam" or "the Company")

Webcast interview with Jonathan Milner, CEO

Abcam plc (AIM: ABC), the rapidly growing bioscience company that markets antibodies via its own online catalogue, is pleased to announce that a webcast interview with Jonathan Milner, the Company's Chief Executive Officer, is ready to view at the London Stock Exchange website:

www.londonstockexchange.com/growing-company-interviews

In the interview, Dr Milner discusses the dynamics of the antibody marketplace and gives an insight into Abcam's history and operations, highlighting the importance of the internet to the Company's business model.

The interview marks the beginning of a series of webcasts hosted by the London Stock Exchange entitled Growing Company Interviews. The interviews are designed to give investors a better understanding of selected companies quoted on the London market.

For further information please contact:

Abcam + 44 (0) 1223 696000

Jonathan Milner, Chief Executive Officer

Jeff Iliffe, Chief Financial Officer

www.abcam.com

Buchanan Communications + 44 (0) 20 7466 5000

Mark Court / Stasa Filiplic

Notes for editors

About Abcam plc

Abcam is a producer and distributor of research-grade antibodies headquartered in Cambridge, United Kingdom, with subsidiaries in Cambridge, Massachusetts, Tokyo and Hong Kong. Abcam was admitted to AIM in November 2005 and trades under the ticker symbol ABC. The Company produces and distributes its own and third-party produced antibodies and related products to academic and commercial users throughout the world. Product ordering is available through the Company's website www.abcam.com, where customers are also able to access up-to-date and detailed technical product data sheets. All the antibodies are sold under the Abcam brand name. Abcam's mission is to develop the largest catalogue of the best antibodies in the world, with the vision of becoming a global leader in the wider protein detection and regulation markets. Abcam now has a rapidly growing online catalogue and as at 30 June 2010 it contained 63,000 products, most of which are antibodies, from over 250 suppliers. Abcam employs 270 staff in its four operating companies.